Inhibition of STAT3 and ErbB2 Suppresses Tumor Growth, Enhances Radiosensitivity, and Induces Mitochondria-Dependent Apoptosis in Glioma Cells
Journal Article
·
· International Journal of Radiation Oncology, Biology and Physics
OSTI ID:21451140
- Department of Experimental Therapy of ARS, Beijing Institute of Radiation Medicine, Beijing (China)
Purpose: Constitutively activated signal transducer and activator of transcription 3 (STAT3) and ErbB2 are involved in the pathogenesis of many tumors, including astrocytoma. Inactivation of these molecules is reported to result in radiosensitization. The purpose of this study was to investigate whether inhibition of STAT3, ErbB2, or both could enhance radiotherapy in the human glioma model (U251 and U87 cell lines). Methods and Materials: The RNAi plasmids targeting STAT3 or ErbB2 were constructed, and their downregulatory effects on target proteins were examined by immunoblotting. After combination treatment of RNAi with or without irradiation, the cell viability was determined using 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) and clonogenic assays. The in vivo effect of combined treatment was determined using the U251 xenograft model. The apoptosis caused by the inhibition of STAT3 and ErbB2 was detected, and the mechanism involved in the apoptosis was investigated, including increases in caspase proteins, mitochondrial damage, and the expression of key modulating protein of different apoptosis pathways. Results: Transfection of U251 cells with STAT3 or ErbB2 siRNA plasmids specifically reduced their target gene expressions. Inhibition of STAT3 or ErbB2 greatly decreased glioma cell survival after 2, 4, or 6 Gy irradiation. Inhibition of STAT3 and ErbB2 also enhanced radiation-induced tumor growth inhibition in the U251 xenograft model. Furthermore, the suppression of either STAT3 or ErbB2 could induce U251 cell apoptosis, which was related primarily to the mitochondrial apoptotic pathway. Conclusions: These results indicated that simultaneous inhibition of STAT3 and ErbB2 expression can promote potent antitumor activity and radiosensitizing activity in human glioma.
- OSTI ID:
- 21451140
- Journal Information:
- International Journal of Radiation Oncology, Biology and Physics, Journal Name: International Journal of Radiation Oncology, Biology and Physics Journal Issue: 4 Vol. 77; ISSN IOBPD3; ISSN 0360-3016
- Country of Publication:
- United States
- Language:
- English
Similar Records
Suppression of autophagy augments the radiosensitizing effects of STAT3 inhibition on human glioma cells
RBM17 controls apoptosis and proliferation to promote Glioma progression
Oridonin interrupts cellular bioenergetics to suppress glioma cell growth by downâregulatingPCK2
Journal Article
·
Wed Jan 14 23:00:00 EST 2015
· Experimental Cell Research
·
OSTI ID:22416970
RBM17 controls apoptosis and proliferation to promote Glioma progression
Journal Article
·
Mon Oct 15 00:00:00 EDT 2018
· Biochemical and Biophysical Research Communications
·
OSTI ID:23107847
Oridonin interrupts cellular bioenergetics to suppress glioma cell growth by downâregulating
Journal Article
·
Tue Jan 12 19:00:00 EST 2021
· PTR. Phytotherapy research
·
OSTI ID:1784569
Related Subjects
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
APOPTOSIS
AZOLES
CELL CONSTITUENTS
CHLORIDES
CHLORINE COMPOUNDS
DISEASES
GLIOMAS
GROWTH
HALIDES
HALOGEN COMPOUNDS
HETEROCYCLIC COMPOUNDS
INHIBITION
MEDICINE
MITOCHONDRIA
NEOPLASMS
NERVOUS SYSTEM DISEASES
NUCLEAR MEDICINE
ORGANIC COMPOUNDS
ORGANIC NITROGEN COMPOUNDS
PLASMIDS
PROTEINS
RADIOLOGY
RADIOSENSITIVITY
RADIOTHERAPY
SENSITIVITY
TETRAZOLES
TETRAZOLIUM
THERAPY
APOPTOSIS
AZOLES
CELL CONSTITUENTS
CHLORIDES
CHLORINE COMPOUNDS
DISEASES
GLIOMAS
GROWTH
HALIDES
HALOGEN COMPOUNDS
HETEROCYCLIC COMPOUNDS
INHIBITION
MEDICINE
MITOCHONDRIA
NEOPLASMS
NERVOUS SYSTEM DISEASES
NUCLEAR MEDICINE
ORGANIC COMPOUNDS
ORGANIC NITROGEN COMPOUNDS
PLASMIDS
PROTEINS
RADIOLOGY
RADIOSENSITIVITY
RADIOTHERAPY
SENSITIVITY
TETRAZOLES
TETRAZOLIUM
THERAPY